Implications of chemokines, chemokine receptors, and inflammatory lipids in atherosclerosis

Journal of Leukocyte Biology

Volumn 95, Issue 4, 2014, Pages 575-585

  Rolin, Johannes ^a   Maghazachi, Azzam A ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Atherosclerotic plaque; HODE; Linoleic acid; Monocytes; Sphingosine 1 phosphate; Statins

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; FINGOLIMOD; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; OXIDIZED LOW DENSITY LIPOPROTEIN;

ARTERY ENDOTHELIUM; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL TYPE; CHRONIC INFLAMMATION; CYTOKINE RELEASE; DISEASE COURSE; ENDOTHELIUM CELL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LEUKOCYTE; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; T LYMPHOCYTE;

ATHEROSCLEROTIC PLAQUE; HODE; LINOLEIC ACID; MONOCYTES; SPHINGOSINE 1-PHOSPHATE; STATINS;

ANIMALS; ATHEROSCLEROSIS; CHEMOKINES; DENDRITIC CELLS; HUMANS; LINOLEIC ACIDS; LINOLEIC ACIDS, CONJUGATED; LIPIDS; LIPOPROTEINS, LDL; LYSOPHOSPHOLIPIDS; RECEPTORS, CHEMOKINE; SPHINGOSINE;

EID: 84899802905     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1113571     Document Type: Review

References (133)

1. Weber, C., Zernecke, A., Libby, P. (2008) The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat. Rev. Immunol. 8, 802-815.
2. Gerrity, R. G., Naito, H. K., Richardson, M., Schwartz, C. J. (1979) Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages. Am. J. Pathol. 95, 775-792.
3. Napoli, C., D'Armiento, F. P., Mancini, F. P., Postiglione, A., Witztum, J. L., Palumbo, G., Palinski, W. (1997) Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J. Clin. Invest. 100, 2680-2690.
4. Ylitalo, R., Oksala, O., Yla-Herttuala, S., Ylitalo, P. (1994) Effects of clodronate (dichloromethylene bisphosphonate) on the development of experimental atherosclerosis in rabbits. J. Lab. Clin. Med. 123, 769-776.
5. Stoneman, V., Braganza, D., Figg, N., Mercer, J., Lang, R., Goddard, M., Bennett, M. (2007) Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques. Circ. Res. 100, 884-893.
6. Swirski, F. K., Pittet, M. J., Kircher, M. F., Aikawa, E., Jaffer, F. A., Libby, P., Weissleder, R. (2006) Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc. Natl. Acad. Sci. USA 103, 10340-10345.
7. Afiune, N. A., Mansur, A. P., Avakian, S. D., Gomes, E. P., Ramires, J. A. (2006) Monocytosis is an independent risk marker for coronary artery disease. Arq. Bras. Cardiol. 86, 240-244.
8. Ley, K., Laudanna, C., Cybulsky, M. I., Nourshargh, S. (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678-689.
9. Chatzizisis, Y. S., Coskun, A. U., Jonas, M., Edelman, E. R., Feldman, C. L., Stone, P. H. (2007) Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J. Am. Coll. Cardiol. 49, 2379-2393.
10. Bernardo, A., Ball, C., Nolasco, L., Choi, H., Moake, J. L., Dong, J. F. (2005) Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress. J. Thromb. Haemost. 3, 562-570.
11. Auffray, C., Fogg, D., Garfa, M., Elain, G., Join-Lambert, O., Kayal, S., Sarnacki, S., Cumano, A., Lauvau, G., Geissmann, F. (2007) Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317, 666-670.
12. Woollard, K. J., Geissmann, F. (2010) Monocytes in atherosclerosis: subsets and functions. Nat. Rev. Cardiol. 7, 77-86.
13. Landsman, L., Bar-On, L., Zernecke, A., Kim, K. W., Krauthgamer, R., Shagdarsuren, E., Lira, S. A., Weissman, I. L., Weber, C., Jung, S. (2009) CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 113, 963-972.
14. Rusinol, A. E., Yang, L., Thewke, D., Panini, S. R., Kramer, M. F., Sinensky, M. S. (2000) Isolation of a somatic cell mutant resistant to the induction of apoptosis by oxidized low density lipoprotein. J. Biol. Chem. 275, 7296-7303.
15. Wintergerst, E. S., Jelk, J., Rahner, C., Asmis, R. (2000) Apoptosis induced by oxidized low density lipoprotein in human monocyte-derived macrophages involves CD36 and activation of caspase-3. Eur. J. Biochem. 267, 6050-6059.
16. Hazen, S. L. (2008) Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity. J. Biol. Chem. 283, 15527-15531.
17. Febbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P., Hazen, S. L., Hoff, H. F., Sharma, K., Silverstein, R. L. (2000) Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. 105, 1049-1056.
18. Park, Y. M., Febbraio, M., Silverstein, R. L. (2009) CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J. Clin. Invest. 119, 136-145.
19. Swirski, F. K., Libby, P., Aikawa, E., Alcaide, P., Luscinskas, F. W., Weissleder, R., Pittet, M. J. (2007) Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J. Clin. Invest. 117, 195-205.
20. Raman, D., Sobolik-Delmaire, T., Richmond, A. (2011) Chemokines in health and disease. Exp. Cell. Res. 317, 575-589.
21. Maghazachi, A. A. (2010) Role of chemokines in the biology of natural killer cells. Curr. Top. Microbiol. Immunol. 341, 37-58.
22. Maghazachi, A. A. (2003) G protein-coupled receptors in natural killer cells. J. Leukoc. Biol. 74, 16-24.
23. Kredel, S., Wolff, M., Hobbie, S., Bieler, M., Gierschik, P., Heilker, R. (2011) High-content analysis of CCR2 antagonists on human primary monocytes. J. Biomol. Screen. 16, 683-693.
24. Soehnlein, O., Drechsler, M., Doring, Y., Lievens, D., Hartwig, H., Kemmerich, K., Ortega-Gomez, A., Mandl, M., Vijayan, S., Projahn, D., Garlichs, C. D., Koenen, R. R., Hristov, M., Lutgens, E., Zernecke, A., Weber, C. (2013) Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes. EMBO Mol. Med. 5, 471-481.
25. Benitez, M. B., Cuniberti, L., Fornari, M. C., Gomez, R. L., Berardi, V., Elikir, G., Stutzbach, P., Schreier, L., Wikinski, R., Brites, F. (2008) Endothelial and leukocyte adhesion molecules in primary hypertriglyceridemia. Atherosclerosis 197, 679-687.
26. Butoi, E. D., Gan, A. M., Manduteanu, I., Stan, D., Calin, M., Pirvulescu, M., Koenen, R. R., Weber, C., Simionescu, M. (2011) Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules. Biochim. Biophys. Acta 1813, 2026-2035.
27. Liu, P., Yu, Y. R., Spencer, J. A., Johnson, A. E., Vallanat, C. T., Fong, A. M., Patterson, C., Patel, D. D. (2008) CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden. Arterioscler. Thromb. Vasc. Biol. 28, 243-250.
28. Barlic, J., Zhang, Y., Foley, J. F., Murphy, P. M. (2006) Oxidized lipiddriven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor γ-dependent pathway. Circulation 114, 807-819.
29. Lesnik, P., Haskell, C. A., Charo, I. F. (2003) Decreased atherosclerosis in CX3CR1-/-mice reveals a role for fractalkine in atherogenesis. J. Clin. Invest. 111, 333-340.
30. McDermott, D. H., Halcox, J. P., Schenke, W. H., Waclawiw, M. A., Merrell, M. N., Epstein, N., Quyyumi, A. A., Murphy, P. M. (2001) Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ. Res. 89, 401-407.
31. Moatti, D., Faure, S., Fumeron, F., Amara, M., Seknadji, P., McDermott, D. H., Debre, P., Aumont, M. C., Murphy, P. M., de Prost, D., Combadiere, C. (2001) Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97, 1925-1928
32. Combadiere, C., Potteaux, S., Gao, J. L., Esposito, B., Casanova, S., Lee, E. J., Debre, P., Tedgui, A., Murphy, P. M., Mallat, Z. (2003) Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 107, 1009-1016.
33. McDermott, D. H., Fong, A. M., Yang, Q., Sechler, J. M., Cupples, L. A., Merrell, M. N., Wilson, P. W., D'Agostino, R. B., O'Donnell, C. J., Patel, D. D., Murphy, P. M. (2003) Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J. Clin. Invest. 111, 1241-1250.
34. Boring, L., Gosling, J., Cleary, M., Charo, I. F. (1998) Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894-897.
35. Aiello, R. J., Bourassa, P. A., Lindsey, S., Weng, W., Natoli, E., Rollins, B. J., Milos, P. M. (1999) Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 19, 1518-1525.
36. Han, K. H., Chang, M. K., Boullier, A., Green, S. R., Li, A., Glass, C. K., Quehenberger, O. (2000) Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferatoractivated receptor γ. J. Clin. Invest. 106, 793-802.
37. Wan, W., Lim, J. K., Lionakis, M. S., Rivollier, A., McDermott, D. H., Kelsall, B. L., Farber, J. M., Murphy, P. M. (2011) Genetic deletion of chemokine receptor Ccr6 decreases atherogenesis in ApoE-deficient mice. Circ. Res. 109, 374-381.
38. Manthey, H. D., Cochain, C., Barnsteiner, S., Karshovska, E., Pelisek, J., Koch, M., Chaudhari, S. M., Busch, M., Eckstein, H. H., Weber, C., Koenen, R. R., Zernecke, A. (2013) CCR6 selectively promotes monocyte mediated inflammation and atherogenesis in mice. Thromb. Haemost. 110, 1267-1277.
39. Von, H. P., Weber, K. S., Huo, Y., Proudfoot, A. E., Nelson, P. J., Ley, K., Weber, C. (2001) RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 103, 1772-1777.
40. Gerszten, R. E., Garcia-Zepeda, E. A., Lim, Y. C., Yoshida, M., Ding, H. A., Gimbrone M. A., Jr., Luster, A. D., Luscinskas, F. W., Rosenzweig, A. (1999) MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398, 718-723.
41. Smith, D. F., Galkina, E., Ley, K., Huo, Y. (2005) GRO family chemokines are specialized for monocyte arrest from flow. Am. J. Physiol. Heart Circ. Physiol. 289, H1976-H1984.
42. Weber, C., Meiler, S., Doring, Y., Koch, M., Drechsler, M., Megens, R. T., Rowinska, Z., Bidzhekov, K., Fecher, C., Ribechini, E., van Zandvoort, M. A., Binder, C. J., Jelinek, I., Hristov, M., Boon, L., Jung, S., Korn, T., Lutz, M. B., Forster, I., Zenke, M., Hieronymus, T., Junt, T., Zernecke, A. (2011) CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J. Clin. Invest. 121, 2898-2910.
43. Aslanian, A. M., Charo, I. F. (2006) Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. Circulation 114, 583-590.
44. Feig, J. E., Rong, J. X., Shamir, R., Sanson, M., Vengrenyuk, Y., Liu, J., Rayner, K., Moore, K., Garabedian, M., Fisher, E. A. (2011) HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. Proc. Natl. Acad. Sci. USA 108, 7166-7171.
45. Trogan, E., Feig, J. E., Dogan, S., Rothblat, G. H., Angeli, V., Tacke, F., Randolph, G. J., Fisher, E. A. (2006) Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. Proc. Natl. Acad. Sci. USA 103, 3781-3786.
46. Feig, J. E., Shang, Y., Rotllan, N., Vengrenyuk, Y., Wu, C., Shamir, R., Torra, I. P., Fernandez-Hernando, C., Fisher, E. A., Garabedian, M. J. (2011) Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages. PLoS One 6, e28534.
47. Luchtefeld, M., Grothusen, C., Gagalick, A., Jagavelu, K., Schuett, H., Tietge, U. J., Pabst, O., Grote, K., Drexler, H., Forster, R., Schieffer, B. (2010) Chemokine receptor 7 knockout attenuates atherosclerotic plaque development. Circulation 122, 1621-1628.
48. Heller, E. A., Liu, E., Tager, A. M., Yuan, Q., Lin, A. Y., Ahluwalia, N., Jones, K., Koehn, S. L., Lok, V. M., Aikawa, E., Moore, K. J., Luster, A. D., Gerszten, R. E. (2006) Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation 113, 2301-2312.
49. Tacke, F., Alvarez, D., Kaplan, T. J., Jakubzick, C., Spanbroek, R., Llodra, J., Garin, A., Liu, J., Mack, M., van, R. N., Lira, S. A., Habenicht, A. J., Randolph, G. J. (2007) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117, 185-194.
50. Saederup, N., Chan, L., Lira, S. A., Charo, I. F. (2008) Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/-mice: evidence for independent chemokine functions in atherogenesis. Circulation 117, 1642-1648.
51. Combadiere, C., Potteaux, S., Rodero, M., Simon, T., Pezard, A., Esposito, B., Merval, R., Proudfoot, A., Tedgui, A., Mallat, Z. (2008) Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 117, 1649-1657.
52. Zernecke, A., Liehn, E. A., Gao, J. L., Kuziel, W. A., Murphy, P. M., Weber, C. (2006) Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10. Blood 107, 4240-4243.
53. Ancuta, P., Rao, R., Moses, A., Mehle, A., Shaw, S. K., Luscinskas, F. W., Gabuzda, D. (2003) Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J. Exp. Med. 197, 1701-1707.
54. Serbina, N. V., Pamer, E. G. (2006) Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 7, 311-317.
55. Schober, A., Zernecke, A., Liehn, E. A., von, H. P., Knarren, S., Kuziel, W. A., Weber, C. (2004) Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets. Circ. Res. 95, 1125-1133.
56. Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., Rollins, B. J. (1998) Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell. 2, 275-281.
57. De Jager, S. C., Bongaerts, B. W., Weber, M., Kraaijeveld, A. O., Rousch, M., Dimmeler, S., van Dieijen-Visser, M. P., Cleutjens, K. B., Nelemans, P. J., Van Berkel, T. J., Biessen, E. A. (2012) Chemokines CCL3/MIP1β, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes. PLoS One 7, e45804.
58. Potteaux, S., Combadiere, C., Esposito, B., Casanova, S., Merval, R., Ardouin, P., Gao, J. L., Murphy, P. M., Tedgui, A., Mallat, Z. (2005) Chemokine receptor CCR1 disruption in bone marrow cells enhances atherosclerotic lesion development and inflammation in mice. Mol. Med. 11, 16-20.
59. Zernecke, A., Schober, A., Bot, I., von, H. P., Liehn, E. A., Mopps, B., Mericskay, M., Gierschik, P., Biessen, E. A., Weber, C. (2005) SDF-1β/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ. Res. 96, 784-791.
60. Schober, A., Knarren, S., Lietz, M., Lin, E. A., Weber, C. (2003) Crucial role of stromal cell-derived factor-1β in neointima formation after vascular injury in apolipoprotein E-deficient mice. Circulation 108, 2491-2497.
61. Han, K. H., Hong, K. H., Ko, J., Rhee, K. S., Hong, M. K., Kim, J. J., Kim, Y. H., Park, S. J. (2004) Lysophosphatidylcholine up-regulates CXCR4 chemokine receptor expression in human CD4 T cells. J. Leukoc. Biol. 76, 195-202.
62. Thomas H. E., Jr., Kannel, W. B., Dawber, T. R., McNamara, P. M. (1966) Cholesterol-phospholipid ratio in the prediction of coronary heart disease. The Framingham study. N. Engl. J. Med. 274, 701-705.
63. Mills, G. L., Taylaur, C. E. (1971) The distribution and composition of serum lipoproteins in eighteen animals. Comp. Biochem. Physiol. 40, 489-501.
64. Soehnlein, O., Drechsler, M., Hristov, M., Weber, C. (2009) Functional alterations of myeloid cell subsets in hyperlipidaemia: relevance for atherosclerosis. J. Cell. Mol. Med. 13, 4293-4303.
65. Stone, N. J., Robinson, J., Lichtenstein, A. H., Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., McBride, P., Schwartz, J. S., Shero, S. T., Smith Jr., S. C., Watson, K., Wilson, P. W. (2013) 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation [Epub ahead of print].
66. Wu, H., Gower, R. M., Wang, H., Perrard, X. Y., Ma, R., Bullard, D. C., Burns, A. R., Paul, A., Smith, C. W., Simon, S. I., Ballantyne, C. M. (2009) Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia. Circulation 119, 2708-2717.
67. Han, K. H., Han, K. O., Green, S. R., Quehenberger, O. (1999) Expression of the monocyte chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia. Differential effects of plasma lipoproteins on monocyte function. J. Lipid Res. 40, 1053-1063.
68. Han, K. H., Tangirala, R. K., Green, S. R., Quehenberger, O. (1998) Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. Arterioscler. Thromb. Vasc. Biol. 18, 1983-1991.
69. Han, K. H., Ryu, J., Hong, K. H., Ko, J., Pak, Y. K., Kim, J. B., Park, S. W., Kim, J. J. (2005) HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo. Circulation 111, 1439-1447.
70. Tani, S., Nagao, K., Anazawa, T., Kawamata, H., Furuya, S., Takahashi, H., Iida, K., Matsumoto, M., Washio, T., Kumabe, N., Hirayama, A. (2009) Association of leukocyte subtype counts with coronary atherosclerotic regression following pravastatin treatment. Am. J. Cardiol. 104, 464-469.
71. Angeli, V., Llodra, J., Rong, J. X., Satoh, K., Ishii, S., Shimizu, T., Fisher, E. A., Randolph, G. J. (2004) Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 21, 561-574.
72. Zaguri, R., Verbovetski, I., Atallah, M., Trahtemberg, U., Krispin, A., Nahari, E., Leitersdorf, E., Mevorach, D. (2007) 'Danger' effect of lowdensity lipoprotein (LDL) and oxidized LDL on human immature dendritic cells. Clin. Exp. Immunol. 149, 543-552.
73. Yilmaz, A., Reiss, C., Tantawi, O., Weng, A., Stumpf, C., Raaz, D., Ludwig, J., Berger, T., Steinkasserer, A., Daniel, W. G., Garlichs, C. D. (2004) HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis. Atherosclerosis 172, 85-93.
74. Kuhn, H. (1996) Biosynthesis, metabolization and biological importance of the primary 15-lipoxygenase metabolites 15-hydro(pero)XY-5Z,8Z,11Z,13E-eicosatetraenoic acid and 13-hydro(pero)XY-9Z,11E-octadecadienoic acid. Prog. Lipid Res. 35, 203-226.
75. Baer, A. N., Costello, P. B., Green, F. A. (1991) Stereospecificity of the hydroxyeicosatetraenoic and hydroxyoctadecadienoic acids produced by cultured bovine endothelial cells. Biochim. Biophys. Acta 1085, 45-52.
76. Yoshida, Y., Niki, E. (2006) Bio-markers of lipid peroxidation in vivo: hydroxyoctadecadienoic acid and hydroxycholesterol. Biofactors 27, 195-202.
77. Yuan, Z. X., Rapoport, S. I., Soldin, S. J., Remaley, A. T., Taha, A. Y., Kellom, M., Gu, J., Sampson, M., Ramsden, C. E. (2013) Identification and profiling of targeted oxidized linoleic acid metabolites in rat plasma by quadrupole time-of-flight mass spectrometry. Biomed. Chromatogr. 27, 422-432.
78. Xie, S., Lee, Y. F., Kim, E., Chen, L. M., Ni, J., Fang, L. Y., Liu, S., Lin, S. J., Abe, J., Berk, B., Ho, F. M., Chang, C. (2009) TR4 nuclear receptor functions as a fatty acid sensor to modulate CD36 expression and foam cell formation. Proc. Natl. Acad. Sci. USA 106, 13353-13358.
79. Obinata, H., Izumi, T. (2009) G2A as a receptor for oxidized free fatty acids. Prostaglandins Other Lipid Mediat. 89, 66-72.
80. Obinata, H., Hattori, T., Nakane, S., Tatei, K., Izumi, T. (2005) Identification of 9-hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G protein-coupled receptor G2A. J. Biol. Chem. 280, 40676-40683.
81. Yin, H., Chu, A., Li, W., Wang, B., Shelton, F., Otero, F., Nguyen, D. G., Caldwell, J. S., Chen, Y. A. (2009) Lipid G protein-coupled receptor ligand identification using β-arrestin PathHunter assay. J. Biol. Chem. 284, 12328-12338.
82. Hattori, T., Obinata, H., Ogawa, A., Kishi, M., Tatei, K., Ishikawa, O., Izumi, T. (2008) G2A plays proinflammatory roles in human keratinocytes under oxidative stress as a receptor for 9-hydroxyoctadecadienoic acid. J. Invest. Dermatol. 128, 1123-1133.
83. Bolick, D. T., Whetzel, A. M., Skaflen, M., Deem, T. L., Lee, J., Hedrick, C. C. (2007) Absence of the G protein-coupled receptor G2A in mice promotes monocyte/endothelial interactions in aorta. Circ. Res. 100, 572-580.
84. Bolick, D. T., Skaflen, M. D., Johnson, L. E., Kwon, S. C., Howatt, D., Daugherty, A., Ravichandran, K. S., Hedrick, C. C. (2009) G2A deficiency in mice promotes macrophage activation and atherosclerosis. Circ. Res. 104, 318-327.
85. Parks, B. W., Gambill, G. P., Lusis, A. J., Kabarowski, J. H. (2005) Loss of G2A promotes macrophage accumulation in atherosclerotic lesions of low density lipoprotein receptor-deficient mice. J. Lipid Res. 46, 1405-1415.
86. Parks, B. W., Lusis, A. J., Kabarowski, J. H. (2006) Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in lowdensity lipoprotein receptor knockout mice. Arterioscler. Thromb. Vasc. Biol. 26, 2703-2709.
87. Parks, B. W., Srivastava, R., Yu, S., Kabarowski, J. H. (2009) ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells. Arterioscler. Thromb. Vasc. Biol. 29, 539-547.
88. Haas, T. A., Bertomeu, M. C., Bastida, E., Buchanan, M. R. (1990) Cyclic AMP regulation of endothelial cell triacylglycerol turnover, 13-hydroxyoctadecadienoic acid (13-HODE) synthesis and endothelial cell thrombogenicity. Biochim. Biophys. Acta 1051, 174-178.
89. Haas, T. A., Bastida, E., Nakamura, K., Hullin, F., Admirall, L., Buchanan, M. R. (1988) Binding of 13-HODE and 5-, 12-and 15-HETE to endothelial cells and subsequent platelet, neutrophil and tumor cell adhesion. Biochim. Biophys. Acta 961, 153-159.
90. Cho, Y., Ziboh, V. A. (1994) Incorporation of 13-hydroxyoctadecadienoic acid (13-HODE) into epidermal ceramides and phospholipids: phospholipase C-catalyzed release of novel 13-HODE-containing diacylglycerol. J. Lipid Res. 35, 255-262.
91. Gron, B., Iversen, L., Ziboh, V., Kragballe, K. (1993) Distribution of monohydroxy fatty acids in specific human epidermal phospholipids. Exp. Dermatol. 2, 38-44.
92. Gron, B., Iversen, L., Ziboh, V., Kragballe, K. (1993) Monohydroxy fatty acids esterified to phospholipids are decreased in lesional psoriatic skin. Arch. Dermatol. Res. 285, 449-454.
93. Miller, C. C., Ziboh, V. A. (1990) Induction of epidermal hyperproliferation by topical n-3 polyunsaturated fatty acids on guinea pig skin linked to decreased levels of 13-hydroxyoctadecadienoic acid (13-hode). J. Invest. Dermatol. 94, 353-358.
94. Kuhn, H., Belkner, J., Wiesner, R., Schewe, T., Lankin, V. Z., Tikhaze, A. K. (1992) Structure elucidation of oxygenated lipids in human atherosclerotic lesions. Eicosanoids 5, 17-22.
95. Waddington, E., Sienuarine, K., Puddey, I., Croft, K. (2001) Identification and quantitation of unique fatty acid oxidation products in human atherosclerotic plaque using high-performance liquid chromatography. Anal. Biochem. 292, 234-244.
96. Waddington, E. I., Croft, K. D., Sienuarine, K., Latham, B., Puddey, I. B. (2003) Fatty acid oxidation products in human atherosclerotic plaque: an analysis of clinical and histopathological correlates. Atherosclerosis 167, 111-120.
97. Wang, D., Strandgaard, S., Iversen, J., Wilcox, C. S. (2009) Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension. Am. J. Physiol. 296, R195-R200.
98. Wittwer, J., Hersberger, M. (2007) The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot. Essent. Fatty Acids 77, 67-77.
99. Zhao, L., Funk, C. D. (2004) Lipoxygenase pathways in atherogenesis. Trends Cardiovasc. Med. 14, 191-195.
100. Kuhn, H., Belkner, J., Zaiss, S., Fahrenklemper, T., Wohlfeil, S. (1994) Involvement of 15-lipoxygenase in early stages of atherogenesis. J. Exp. Med. 179, 1903-1911.
101. Mahipal, S. V., Subhashini, J., Reddy, M. C., Reddy, M. M., Anilkumar, K., Roy, K. R., Reddy, G. V., Reddanna, P. (2007) Effect of 15-lipoxygenase metabolites, 15-(S)-HPETE and 15-(S)-HETE on chronic myelogenous leukemia cell line K-562: reactive oxygen species (ROS) mediate caspase-dependent apoptosis. Biochem. Pharmacol. 74, 202-214.
102. Mani, I., Iversen, L., Ziboh, V. A. (1998) Upregulation of nuclear PKC and MAP-kinase during hyperproliferation of guinea pig epidermis: modulation by 13-(S)-hydroxyoctadecadienoic acid (13-HODE). Cell. Signal. 10, 143-149.
103. Hampel, J. K., Brownrigg, L. M., Vignarajah, D., Croft, K. D., Dharmarajan, A. M., Bentel, J. M., Puddey, I. B., Yeap, B. B. (2006) Differential modulation of cell cycle, apoptosis and PPARγ2 gene expression by PPARα agonists ciglitazone and 9-hydroxyoctadecadienoic acid in monocytic cells. Prostaglandins Leukot. Essent. Fatty Acids 74, 283-293.
104. Jostarndt, K., Gellert, N., Rubic, T., Weber, C., Kuhn, H., Johansen, B., Hrboticky, N., Neuzil, J. (2002) Dissociation of apoptosis induction and CD36 upregulation by enzymatically modified low-density lipoprotein in monocytic cells. Biochem. Biophys. Res. Commun. 290, 988-993.
105. Jostarndt, K., Rubic, T., Kuhn, H., Anthosen, M. W., Andera, L., Gellert, N., Trottman, M., Weber, C., Johansen, B., Hrboticky, N., Neuzil, J. (2004) Enzymatically modified low-density lipoprotein upregulates CD36 in low-differentiated monocytic cells in a peroxisome proliferator-activated receptor-γ-dependent way. Biochem. Pharmacol. 67, 841-854.
106. Nagy, L., Tontonoz, P., Alvarez, J. G., Chen, H., Evans, R. M. (1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 93, 229-240.
107. Shamshiev, A. T., Ampenberger, F., Ernst, B., Rohrer, L., Marsland, B. J., Kopf, M. (2007) Dyslipidemia inhibits Toll-like receptor-induced activation of CD8+-negative dendritic cells and protective Th1 type immunity. J. Exp. Med. 204, 441-452.
108. King, V. L., Szilvassy, S. J., Daugherty, A. (2002) Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/-mice. Arterioscler. Thromb. Vasc. Biol. 22, 456-461.
109. Yilmaz, A., Reiss, C., Weng, A., Cicha, I., Stumpf, C., Steinkasserer, A., Daniel, W. G., Garlichs, C. D. (2006) Differential effects of statins on relevant functions of human monocyte-derived dendritic cells. J. Leukoc. Biol. 79, 529-538.
110. Babaev, V. R., Yancey, P. G., Ryzhov, S. V., Kon, V., Breyer, M. D., Magnuson, M. A., Fazio, S., Linton, M. F. (2005) Conditional knockout of macrophage PPARα increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 25, 1647-1653.
111. Veillard, N. R., Braunersreuther, V., Arnaud, C., Burger, F., Pelli, G., Steffens, S., Mach, F. (2006) Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages. Atherosclerosis 188, 51-58.
112. Rolin, J., Al-Jaderi, Z., Maghazachi, A. A. (2013) Oxidized lipids and lysophosphatidylcholine induce the chemotaxis and intracellular calcium influx in natural killer cells. Immunobiology 218, 875-883.
113. Corti, R., Fuster, V., Fayad, Z. A., Worthley, S. G., Helft, G., Smith, D., Weinberger, J., Wentzel, J., Mizsei, G., Mercuri, M., Badimon, J. J. (2002) Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 106, 2884-2887.
114. Sugiura, T., Dohi, Y., Yamashita, S., Ohte, N., Ito, S., Iwaki, S., Hirowatari, Y., Ohkawa, R., Mishima, Y., Yatomi, Y., Kimura, G., Fujii, S. (2012) Analytical evaluation of plasma serotonin and sphingosine 1-phosphate and their clinical assessment in early atherosclerosis. Coron. Artery Dis. 23, 234-238.
115. Igarashi, J., Miyoshi, M., Hashimoto, T., Kubota, Y., Kosaka, H. (2007) Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins. Br. J. Pharmacol. 150, 470-479.
116. Rivera, J., Proia, R. L., Olivera, A. (2008) The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat. Rev. Immunol. 8, 753-763.
117. Egom, E. E., Rose, R. A., Neyses, L., Soran, H., Cleland, J. G., Mamas, M. A. (2013) Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy. Crit. Rev. Clin. Lab. Sci. 50, 79-89.
118. Egom, E. E., Mamas, M. A., Soran, H. (2013) HDL quality or cholesterol cargo: what really matters-spotlight on sphingosine-1-phosphaterich HDL. Curr. Opin. Lipidol. 24, 351-356.
119. Nofer, J. R., Bot, M., Brodde, M., Taylor, P. J., Salm, P., Brinkmann, V., van, B. T., Assmann, G., Biessen, E. A. (2007) FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 115, 501-508.
120. Schaier, M., Vorwalder, S., Sommerer, C., Dikow, R., Hug, F., Gross, M. L., Waldherr, R., Zeier, M. (2009) Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats. Am. J. Physiol. Renal Physiol. 297, F769-F780.
121. Henning, G., Ohl, L., Junt, T., Reiterer, P., Brinkmann, V., Nakano, H., Hohenberger, W., Lipp, M., Forster, R. (2001) CC Chemokine receptor 7-dependent and-independent pathways for lymphocyte homing: modulation by FTY720. J. Exp. Med. 194, 1875-1881.
122. Honig, S. M., Fu, S., Mao, X., Yopp, A., Gunn, M. D., Randolph, G. J., Bromberg, J. S. (2003) FTY720 stimulates multidrug transporter-and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes. J. Clin. Invest. 111, 627-637.
123. Yopp, A. C., Fu, S., Honig, S. M., Randolph, G. J., Ding, Y., Krieger, N. R., Bromberg, J. S. (2004) FTY720-enhanced T cell homing is dependent on CCR2, CCR5, CCR7, and CXCR4: evidence for distinct chemokine compartments. J. Immunol. 173, 855-865.
124. Muller, G., Reiterer, P., Hopken, U. E., Golfier, S., Lipp, M. (2003) Role of homeostatic chemokine and sphingosine-1-phosphate receptors in the organization of lymphoid tissue. Ann. N. Y. Acad. Sci. 987, 107-116.
125. Ryser, M. F., Ugarte, F., Lehmann, R., Bornhauser, M., Brenner, S. (2008) S1P(1) overexpression stimulates S1P-dependent chemotaxis of human CD34+ hematopoietic progenitor cells but strongly inhibits SDF-1/CXCR4-dependent migration and in vivo homing. Mol. Immunol. 46, 166-171.
126. Yopp, A. C., Ochando, J. C., Mao, M., Ledgerwood, L., Ding, Y., Bromberg, J. S. (2005) Sphingosine 1-phosphate receptors regulate chemokine-driven transendothelial migration of lymph node but not splenic T cells. J. Immunol. 175, 2913-2924.
127. Kimura, T., Boehmler, A. M., Seitz, G., Kuci, S., Wiesner, T., Brinkmann, V., Kanz, L., Mohle, R. (2004) The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34+ progenitor cells. Blood 103, 4478-4486.
128. Walter, D. H., Rochwalsky, U., Reinhold, J., Seeger, F., Aicher, A., Urbich, C., Spyridopoulos, I., Chun, J., Brinkmann, V., Keul, P., Levkau, B., Zeiher, A. M., Dimmeler, S., Haendeler, J. (2007) Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor. Arterioscler. Thromb. Vasc. Biol. 27, 275-282.
129. Golan, K., Vagima, Y., Ludin, A., Itkin, T., Cohen-Gur, S., Kalinkovich, A., Kollet, O., Kim, C., Schajnovitz, A., Ovadya, Y., Lapid, K., Shivtiel, S., Morris, A. J., Ratajczak, M. Z., Lapidot, T. (2012) S1P promotes murine progenitor cell egress and mobilization via S1P1-mediated ROS signaling and SDF-1 release. Blood 119, 2478-2488.
130. Garcia-Bernal, D., Redondo-Munoz, J., Dios-Esponera, A., Chevre, R., Bailon, E., Garayoa, M., Arellano-Sanchez, N., Gutierrez, N. C., Hidalgo, A., Garcia-Pardo, A., Teixido, J. (2013) Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function. J. Pathol. 229, 36-48.
131. Durand, C. A., Westendorf, J., Tse, K. W., Gold, M. R. (2006) The Rap GTPases mediate CXCL13-and sphingosine1-phosphate-induced chemotaxis, adhesion, and Pyk2 tyrosine phosphorylation in B lymphocytes. Eur. J. Immunol. 36, 2235-2249.
132. Rolin, J., Sand, K. L., Knudsen, E., Maghazachi, A. A. (2010) FTY720 and SEW2871 reverse the inhibitory effect of S1P on natural killer cell mediated lysis of K562 tumor cells and dendritic cells but not on cytokine release. Cancer Immunol. Immunother. 59, 575-586.
133. Kanzler, I., Liehn, E. A., Koenen, R. R., Weber, C. (2012) Anti-inflammatory therapeutic approaches to reduce acute atherosclerotic complications. Curr. Pharm. Biotechnol. 13, 37-45.